- About UMPCD
- Education
- Students
- Research and development
- International relations
SOLACE PROJECT
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.
PROJECT NUMBER: This project is co-funded under the EU4Health Programme 2021–2027 under grant agreement no. 101101187
PROJECT NAME: Strengthening the Screening of Lung Cancer in Europe
PROJECT ACRONYM: SOLACE
COORDINATOR: European Institute for Biomedical Imaging Research (EIBIR)
PROJECT START DATE: April 1, 2023
PROJECT END DATE: March 31, 2026
WEBSITES:
https://europeanlung.org/solace/
https://www.eibir.org/projects/solace/
PROJECT STRUCTURE (WORK PACKAGES):
*UMFCD partner
UMFCD PROJECT TEAM:
PROJECT DESCRIPTION:
The Strengthening the Screening of Lung Cancer in Europe (SOLACE) project aims to enhance low-dose computed tomography (CT) screening efforts for lung cancer in Europe. Its main objectives include improving early detection methods, increasing screening accessibility, implementing standardized screening protocols, and enhancing the risk-benefit ratio and cost-effectiveness of lung cancer screening. Additionally, SOLACE aims to raise awareness about lung cancer risk factors and the importance of early detection among healthcare professionals and the general public. Through collaborative efforts and innovative approaches, the project seeks to reduce the burden of lung cancer by promoting timely diagnosis and improving patient outcomes.
ADDITIONAL RESOURCES:
https://europeanlung.org/solace/wp-content/uploads/sites/13/2024/02/Poster_Solace-3_3_online2.pdf
https://connect.myesr.org/course/solace-insight-strengthening-lung-cancer-screening-across-europe/